KC
USNA icon

Kepos Capital’s Usana Health Sciences USNA Stock Holding History

Kepos Capital’s Portfolio USNA Stock Details USNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-14,377
Closed -$1.14M – 402
2019
Q2 		$1.14M Hold
14,377
– – 0.12% 159
2019
Q1 		$1.21M Buy
14,377
+356
+3% +$37.2K 0.09% 200
2018
Q4 		$1.65M Buy
14,021
+7,526
+116% +$870K 0.13% 162
2018
Q3 		$783K Buy
+6,495
New +$806K 0.04% 248

Other funds holding USNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Kepos Capital's USNA Position: Q3 2019 in Review

Kepos Capital sold out of Usana Health Sciences (USNA) in Q3 2019, closing a stake of 14,377 shares — an estimated $1.14M sold.

Kepos Capital first reported a position in USNA in Q3 2018 and held it in 4 quarters. The position peaked at $1.65M in Q4 2018. 169 funds tracked by Wall St. Rank hold USNA as of Q3 2019.

  • Kepos Capital reported no remaining Usana Health Sciences position as of Q3 2019 after selling out during the quarter.
  • Kepos Capital sold 14,377 Usana Health Sciences shares in Q3 2019, an estimated $1.14M.
  • Kepos Capital first reported a position in Usana Health Sciences in Q3 2018 and held it in 4 quarters.
  • Kepos Capital's Usana Health Sciences position peaked at $1.65M in Q4 2018.
  • 169 funds tracked by Wall St. Rank held Usana Health Sciences as of Q3 2019.

Based on Kepos Capital's 13F filing for Q3 2019, filed 13 Nov 2019.